Nutriband receives hong kong patent notice of publication for its aversa™ abuse deterrent transdermal technology

Orlando, fla., nov. 27, 2024 (globe newswire) -- nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a notice of publication of the registration and grant of a standard patent (r) from the hong kong intellectual property department for patent application entitled, “abuse and misuse deterrent transdermal systems,” which protects its aversa™ abuse deterrent transdermal technology.
NTRB Ratings Summary
NTRB Quant Ranking